Nymox Pharmaceutical Corp. engages in the research and development of products for the aging population. Its products include NicAlert, TobacAlert and Fexapotide Triflutate for the treatment of low-grade localized prostate cancer. The company was founded by Paul Averback on May 30, 1995 and is headquartered in Nassau, the Bahamas.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Nymox Pharmaceutical Corp?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Nymox Pharmaceutical Corp market cap is $5.67M.
What is the 52-week high for Nymox Pharmaceutical Corp?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Nymox Pharmaceutical Corp 52 week high is $0.146 as of April 21, 2026.
What is the 52-week low for Nymox Pharmaceutical Corp?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Nymox Pharmaceutical Corp 52 week low is $0.03 as of April 21, 2026.
What is Nymox Pharmaceutical Corp stock price today?
Nymox Pharmaceutical Corp stock price today is $0.035.
What was Nymox Pharmaceutical Corp stock price yesterday?
Nymox Pharmaceutical Corp stock price yesterday was $0.06.
What is the 50-day moving average of Nymox Pharmaceutical Corp?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Nymox Pharmaceutical Corp 50-day moving average is $0.0585.